1-2 of 2
Helena Brillembourg
Close
Sort by
Journal Articles

Varnimcabtagene Autoleucel (ARI-0001) for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Richter Transformation (RT)

Valentin Ortiz-Maldonado, Nuria Martinez-Cibrian, Gonzalo Del Campo Balguerías, Marta Español-Rego, Sergio Navarro, Irene Lopez-Oreja, Ferran Nadeu, Amparo Cobo, Helena Brillembourg, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Juan Gonzalo Correa, Andrea Rivero, Pablo Mozas, Eva Gine, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Mercedes Montoro-Lorite, Pilar Ayora, Carlos Fernández de Larrea, Mariona Pascal, Xavier Setoain, Jordi Esteve Reyner, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Journal: Blood
Blood (2023) 142 (Supplement 1): 3483.
https://doi.org/10.1182/blood-2023-182896
Published: 2023
Journal Articles

Impact of Salvage and Bridging Therapy in Adult Patients with Refractory B-Cell Acute Lymphoblastic Leukemia (B-ALL) Referred for Anti-CD19 CAR T-Cell Therapy: An Intention to Treat Analysis

Valentin Ortiz-Maldonado, Nuria Martinez-Cibrian, Gonzalo Del Campo Balguerías, Marta Español-Rego, Sergio Navarro, Helena Brillembourg, Leticia Alserawan, Maria Castella, Daniel Benitez-Ribas, Laura Magnano, Juan Gonzalo Correa, Andrea Rivero, Pablo Mozas, Aina Oliver-Caldes, Eva Gine, Luis Gerardo Rodríguez-Lobato, Alexandra Martínez-Roca, Mercedes Montoro-Lorite, Pilar Ayora, Carlos Fernández de Larrea, Mariona Pascal, Jordi Esteve Reyner, Alvaro Urbano-Ispizua, Manel Juan, Julio Delgado
Journal: Blood
Blood (2023) 142 (Supplement 1): 4875.
https://doi.org/10.1182/blood-2023-187226
Published: 2023